Attached files
| file | filename |
|---|---|
| EX-99.1 - MAY 2013 INVESTOR PRESENTATION - MedAvail Holdings, Inc. | f8k052013ex99i_myos.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 22, 2013
MYOS CORPORATION
(Exact name of registrant as specified in its charter)
|
Nevada
|
000-53298
|
20-8758875
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
45 Horsehill Road, Suite 106
Cedar Knolls, New Jersey 07927
(Address of Principal Executive Offices)
(973) 509-0444
(Issuer’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01. Regulation FD Disclosure.
MYOS Corporation (the “Company”) will be conducting meetings with investors beginning on May 22, 2013. Attached as Exhibit 99.1 are the presentation slides (the “Presentation”) to be used at such meetings. The Presentation notes the number of units of MYO-X (the Company’s sole product) shipped by the Company's exclusive distributor to retailers from February 2013 through April 2013. Specifically, the Company's exclusive distributor shipped 3,674 units in February 2013, 6,797 units in March 2013 and 9,594 units in April 2013.
The information in this Current Report on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
99.1
|
May 2013 Investor Presentation.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 22, 2013
|
MYOS CORPORATION
|
|||
|
By:
|
/s/ Peter Levy
|
||
|
Name: Peter Levy
|
|||
|
Title: President
|
|||